Way back in 1997 a company launched one of the first commercial expression microarrays. The company was Affymetrix, the technology…
Every mother-to-be who has what is considered an 'at-risk' pregnancy is informed of the risks to the fetus of a…
Immunology is a fascinating subject. Immense in its complexity, debilitating when the immune system malfunctions, our ability to fend off…
A few weeks ago this paper appeared in Nature Biotechnology, "Genome mapping on nanochannel arrays for structural variation analysis and…
NanoString is a startup company that has commercialized a product called the nCounter™ system. It is able to take an…
Today I learned that Charles Lindbergh flew non-stop from New York City to Paris in 1927 as a result of…
There is a lot of interest in what is the Next Big Thing in next-generation sequencing. The case can be…
This week a remarkable paper was published in Nature, called "Accurate whole-genome sequencing and haplotyping from 10 to 20 human…
Although the whole genome versus whole exome discussion was held previously, details around the methods of selecting out the whole…
In previous posts I covered the basics of next-generation sequencing - library preparation, template preparation, and the sequencing methodology itself,…